Gregory Hinkle

🏛 Authors' Affiliations: 1Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona; 2Institute of Health Research INCLIVA, University of Valencia, Valencia; 3Hospital Virgen del Rocio, Seville, Spain; 4Dana-Farber Cancer Institute; 5Beth Israel Deaconess Medical Center, Boston; 6Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts; 7Karmanos Cancer Institute, Detroit, Michigan; 8Memorial Sloan-Kettering Cancer Center, New York, New York; 9Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; and 10Sarah Cannon Research Institute, Nashville, Tennessee